Research theme for competitive and other funds (12)：
2014 - 2017 The roles of cancer stem cells and driver genes for clarifying the mechanism of lung cancer from COPD
2012 - 2015 Birt-Hogg-Dube syndrome: Molecular analysis and diagnosis of related lesions
2011 - 2013 Challenge for early detection of lung cancer and investigation of carcinogenesis in patients with COPD
2009 - 2011 Role of BHD gene in the development of pulmonary cysts and cancer : A molecular-pathological analysis
2007 - 2008 Tai-or-madetreat ment for lung cancer using EBUS-TBNA
2007 - 2008 Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer
2007 - 2008 Pathogenesis of malignant pleural mesothelioma
2006 - 2007 Screening and validation of target molecules involved in mechanism of multi-modality therapy
2005 - 2006 The strategy based on gene expression profiling using microarray for tailor-made treatment in patients with lung cancer
2005 - 2006 molecular and pathological study on pathogenesis of cystic lung diseases : Analysis of congenital cystic adenomatoid malformation as a model.
2004 - 2006 Relation between tumor cells and stromal cells in primary lung carcinoma via Akt signal pathway
1991 - 1992 Hyperplasia of distal airway epithelium due to aging among residents in the area where the incidence of lung cancer is high.
Show all
Papers (343)：
Ken Arimura, Kenzo Hiroshima, Yoji Nagashima, Tadao Nakazawa, Akira Ogihara, Mami Orimo, Yasuto Sato, Hideki Katsura, Masato Kanzaki, Mitsuko Kondo, et al. LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study. BMC cancer. 2023. 23. 1. 1206-1206
Yoshitaka Furuya, Kenzo Hiroshima, Takashi Wakahara, Harutoshi Akimoto, Shigeo Kawai, Masayuki Ota, Yukio Nakatani, Akinori Furuya, Hironobu Yanagie. Metaplastic breast carcinoma producing prominent basal lamina with neuroendocrine differentiation: A case report. Molecular and clinical oncology. 2023. 18. 5. 36-36
Prakasit Sa-Ngiamwibool, Makoto Hamasaki, Yoshiaki Kinoshita, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara, Takahiko Kasai, Kei Kushitani, Yukio Takeshima, et al. Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study. Lung cancer (Amsterdam, Netherlands). 2023. 175. 27-35
Prakasit Sa-Ngiamwibool, Makoto Hamasaki, Yoshiaki Kinoshita, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Takahiko Kasai, Kenzo Hiroshima, Kei Kushitani, Yukio Takeshima, et al. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features. Annals of diagnostic pathology. 2022. 60. 152004-152004
Takahiro Ochi, Teruaki Mizobuchi, Kenzo Hiroshima, Kaoru Nagato, Taku Itoh, Fuminobu Kuroda, Kazuto Yamazaki, Ikuma Kato, Masanori Hisaoka, Yukio Nakatani. A successful trimodality therapy for difficult-to-diagnose primary mediastinal dedifferentiated liposarcoma, which originated from the perihilar fat and invaded the right lungs. GENERAL THORACIC AND CARDIOVASCULAR SURGERY. 2021
Cytological diagnosis of malignant mesothelioma.
(2018)
HEG1 is a new immunohistochemical marker for the pathological diagnosis of malignant mesothelioma.
(14th International Conference of the International Mesothelioma Interest Group 2018)
HEG1 is a Novel Mucin-like Membrane Protein That is Useful for the Diagnosis of Malignant Mesothelioma.
(USCAP 2018 Annual Meeting 2018)
FISH Analysis of p16 and BAP1 Immunohistochemistry for the Diagnosis of Mesothelioma.
(IASLC 18th World Conference on Lung Cancer 2017)
Scientific Highlights - Biology/Pathology and Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
(IASLC 18th World Conference on Lung Cancer 2017)
